UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market trading Thursday. Shares of Elevance gained more than 4% to $408 a share before the bell.
Elevance Health: Q4 Earnings Snapshot
The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share.
Elevance Health Raises Quarterly Dividend by 4.9% to $1.71
Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an annual yield of about 1.75%, based on Wednesday's closing price of $390.73, up from 1.67%.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock jumped 5% in premarket trade Thursday and boosted other health insurance stocks, after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns after a big miss in the third quarter.
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
Shares of Elevance Health Inc. climbed over 2.5% on Thursday morning, hitting levels last seen in early December. The rise came as the health insurer reported better-than-expected fourth-quarter results and provided an upbeat outlook for 2025.
Benefits Pro3d
Elevance is glad it raised commercial health insurance prices for 2025
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
Elevance Health: Attractive Valuation and Stable Growth Prospects Drive Buy Rating
Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond ...
Benefits Pro3d
Elevance expects commercial health cost trends to stay high
Elevance executives talked about the cost trend environment for employer health plans Thursday, during a conference call with securities analysts. The Indianapolis-based health insurer and ...
Healthcare Dive3d
Elevance’s fourth-quarter profit slashed in half amid higher Medicaid costs
In a call with investors, CEO Gail Boudreaux didn’t directly address the killing of UnitedHealthcare’s top executive but spent more time than usual arguing Elevance is working to improve healthcare.